CanSino Biologics' HK shares rise on inhalable COVID vaccine launch in Tianjin

Cansino Biologics

10/11/2022 04:09

** Hong Kong-listed shares of CanSino Biologics Inc
 6185.HK  rise as much as 11.8% to HK$119.80, their biggest
intraday pct gain since Nov 4
    ** Stock on course to snap two straight session of losses
and is sixth-biggest pct gainer in Hang Seng Composite Index
 .HSCI  
    ** CanSino Biologics said on Wednesday its inhalable
COVID-19 vaccines would be available in Tianjin from Nov. 10 and
citizens could make appointment to receive them  urn:newsml:reuters.com:*:nL4T3253YN
    ** Shanghai shares of CanSino Biologics  688185.SS  gain
1.1% 
    ** Hang Seng Commerce & Industry Index  .HSNC  falls 2.2%
and healthcare index  .HSCIH  declines 1.9%
    ** Hang Seng Composite Index  .HSCI  and Hang Seng Index
 .HSI  both drop 1.9%
    ** As of last close, the Hong Kong-listed shares down 40.5%
this year, while Shanghai stock was down 20.5%
 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))